132 related articles for article (PubMed ID: 10491313)
1. Arsenic disrupts cellular levels of p53 and mdm2: a potential mechanism of carcinogenesis.
Hamadeh HK; Vargas M; Lee E; Menzel DB
Biochem Biophys Res Commun; 1999 Sep; 263(2):446-9. PubMed ID: 10491313
[TBL] [Abstract][Full Text] [Related]
2. The repressive effect of NF-kappaB on p53 by mot-2 is involved in human keratinocyte transformation induced by low levels of arsenite.
Li Y; Ling M; Xu Y; Wang S; Li Z; Zhou J; Wang X; Liu Q
Toxicol Sci; 2010 Jul; 116(1):174-82. PubMed ID: 20375080
[TBL] [Abstract][Full Text] [Related]
3. Opposed arsenite-mediated regulation of p53-survivin is involved in neoplastic transformation, DNA damage, or apoptosis in human keratinocytes.
Li Y; Jiang R; Zhao Y; Xu Y; Ling M; Pang Y; Shen L; Zhou Y; Zhang J; Zhou J; Wang X; Liu Q
Toxicology; 2012 Oct; 300(3):121-31. PubMed ID: 22706169
[TBL] [Abstract][Full Text] [Related]
4. Differentially Expressed mRNA Targets of Differentially Expressed miRNAs Predict Changes in the TP53 Axis and Carcinogenesis-Related Pathways in Human Keratinocytes Chronically Exposed to Arsenic.
Al-Eryani L; Waigel S; Tyagi A; Peremarti J; Jenkins SF; Damodaran C; States JC
Toxicol Sci; 2018 Apr; 162(2):645-654. PubMed ID: 29319823
[TBL] [Abstract][Full Text] [Related]
5. Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns.
Golub MS; Macintosh MS; Baumrind N
J Toxicol Environ Health B Crit Rev; 1998; 1(3):199-241. PubMed ID: 9644328
[TBL] [Abstract][Full Text] [Related]
6. Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms.
Sakurai T; Kaise T; Matsubara C
Chem Res Toxicol; 1998 Apr; 11(4):273-83. PubMed ID: 9548797
[TBL] [Abstract][Full Text] [Related]
7. Aberrant cytokeratin expression during arsenic-induced acquired malignant phenotype in human HaCaT keratinocytes consistent with epidermal carcinogenesis.
Sun Y; Pi J; Wang X; Tokar EJ; Liu J; Waalkes MP
Toxicology; 2009 Aug; 262(2):162-70. PubMed ID: 19524636
[TBL] [Abstract][Full Text] [Related]
8. Arsenite-mediated promotion of anchorage-independent growth of HaCaT cells through placental growth factor.
Yajima I; Kumasaka MY; Ohnuma S; Ohgami N; Naito H; Shekhar HU; Omata Y; Kato M
J Invest Dermatol; 2015 Apr; 135(4):1147-1156. PubMed ID: 25493652
[TBL] [Abstract][Full Text] [Related]
9. Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes.
Ding W; Hudson LG; Liu KJ
Mol Cell Biochem; 2005 Nov; 279(1-2):105-12. PubMed ID: 16283519
[TBL] [Abstract][Full Text] [Related]
10. Arsenic-induced dyslipidemia in male albino rats: comparison between trivalent and pentavalent inorganic arsenic in drinking water.
Afolabi OK; Wusu AD; Ogunrinola OO; Abam EO; Babayemi DO; Dosumu OA; Onunkwor OB; Balogun EA; Odukoya OO; Ademuyiwa O
BMC Pharmacol Toxicol; 2015 Jun; 16():15. PubMed ID: 26044777
[TBL] [Abstract][Full Text] [Related]
11. Physiologically based pharmacokinetic modeling of arsenic in the mouse.
Gentry PR; Covington TR; Mann S; Shipp AM; Yager JW; Clewell HJ
J Toxicol Environ Health A; 2004 Jan; 67(1):43-71. PubMed ID: 14668111
[TBL] [Abstract][Full Text] [Related]
12. Arsenite cocarcinogenesis: an animal model derived from genetic toxicology studies.
Rossman TG; Uddin AN; Burns FJ; Bosland MC
Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):749-52. PubMed ID: 12426125
[TBL] [Abstract][Full Text] [Related]
13. CD44v6 expression in human skin keratinocytes as a possible mechanism for carcinogenesis associated with chronic arsenic exposure.
Huang S; Guo S; Guo F; Yang Q; Xiao X; Murata M; Ohnishi S; Kawanishi S; Ma N
Eur J Histochem; 2013 Jan; 57(1):e1. PubMed ID: 23549458
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of p53 and MDM2 in human atherosclerosis: implications for the regulation of cellularity of atherosclerotic lesions.
Ihling C; Haendeler J; Menzel G; Hess RD; Fraedrich G; Schaefer HE; Zeiher AM
J Pathol; 1998 Jul; 185(3):303-12. PubMed ID: 9771485
[TBL] [Abstract][Full Text] [Related]
15. p53 response to arsenic exposure in epithelial cells: protein kinase B/Akt involvement.
Sandoval M; Morales M; Tapia R; del Carmen Alarcón L; Sordo M; Ostrosky-Wegman P; Ortega A; López-Bayghen E
Toxicol Sci; 2007 Sep; 99(1):126-40. PubMed ID: 17567589
[TBL] [Abstract][Full Text] [Related]
16. [Dynamic changes of ROS, MDA and SOD during arsenic-induced neoplastic transformation in human keratinocytes].
Ma Y; Wang D; Xu X; Yang X; Wang X; Zhu Z; Zhao Y; Chen M; Xu F; Fu L; Zhu J; Gao F; An Y
Wei Sheng Yan Jiu; 2015 May; 44(3):456-61. PubMed ID: 26137629
[TBL] [Abstract][Full Text] [Related]
17. Effect of glutathione depletion and metallothionein gene expression on arsenic-induced cytotoxicity and c-myc expression in vitro.
Shimizu M; Hochadel JF; Fulmer BA; Waalkes MP
Toxicol Sci; 1998 Oct; 45(2):204-11. PubMed ID: 9848127
[TBL] [Abstract][Full Text] [Related]
18. N
Zhao T; Sun D; Zhao M; Lai Y; Liu Y; Zhang Z
Environ Pollut; 2020 Apr; 259():113908. PubMed ID: 31931413
[TBL] [Abstract][Full Text] [Related]
19. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes.
Vega L; Styblo M; Patterson R; Cullen W; Wang C; Germolec D
Toxicol Appl Pharmacol; 2001 May; 172(3):225-32. PubMed ID: 11312651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
